A Randomized, Double-Blind, Parallel Group, Active- and Placebo-Controlled Study to Assess the Efficacy and Safety of JNJ26489112 in Adult Subjects With Treatment-Resistant Major Depressive Disorder.

Trial Profile

A Randomized, Double-Blind, Parallel Group, Active- and Placebo-Controlled Study to Assess the Efficacy and Safety of JNJ26489112 in Adult Subjects With Treatment-Resistant Major Depressive Disorder.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Feb 2013

At a glance

  • Drugs JNJ 26489112 (Primary) ; Venlafaxine
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jan 2013 Actual initiation date changed from Jun 2010 to Mar 2011 as reported by ClinicalTrials.gov.
    • 12 Mar 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 12 Aug 2011 Planned end date changed from 1 May 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top